EPPTB
Enhanced Permeability and Retention Effect[edit | edit source]
The Enhanced Permeability and Retention (EPR) Effect is a phenomenon observed in tumor biology, where macromolecular drugs and nanoparticles preferentially accumulate in tumor tissue. This effect is primarily due to the unique characteristics of tumor vasculature and the impaired lymphatic drainage in tumors.
Mechanism[edit | edit source]
The EPR effect is driven by two main factors:
- Enhanced Permeability: Tumor blood vessels are often irregular, disorganized, and have wide fenestrations. This allows macromolecules and nanoparticles to pass through the vessel walls more easily than in normal tissues.
- Retention: Tumors typically have poor lymphatic drainage, which means that once macromolecules and nanoparticles enter the tumor tissue, they are retained for longer periods.
These factors together enable the selective accumulation of therapeutic agents in tumor tissues, which can enhance the efficacy of cancer treatments while minimizing systemic side effects.
Applications[edit | edit source]
The EPR effect is exploited in the design of nanomedicines and drug delivery systems. By engineering drugs to be of a certain size and composition, researchers can increase the likelihood that these drugs will accumulate in tumor tissues via the EPR effect. This has led to the development of various nanoparticle-based therapies and liposome-encapsulated drugs.
Challenges[edit | edit source]
Despite its potential, the EPR effect is not uniformly effective across all tumor types or patients. Factors such as tumor type, size, location, and the presence of hypoxia can influence the extent of the EPR effect. Additionally, the heterogeneity of tumor vasculature can lead to variable drug delivery and efficacy.
Future Directions[edit | edit source]
Research is ongoing to better understand the EPR effect and to develop strategies to enhance its effectiveness. Approaches include the use of vascular normalization agents, hyperthermia, and ultrasound to improve drug delivery to tumors.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
